Alcon Inc (ALC)



Alcon Inc. manufactures eye care products. The Company produces and markets vitreoretinal and cataract surgery, contact lenses, and refractive technology products. Alcon serves medical industry worldwide.

Data as of 2020-09-12
Market Cap27.243 Billion Shares Outstanding489.1 Million Avg 30-day Volume1.207 Million
P/E Ratio Dividend Yield EPS-1.21
Price/Sales4.214 Price cash flow ratio42.5 Price free cash flow ratio-148.8
Book Value35.01 Price to Tangible Book153.01 Alpha-0.01
Short Interest Ratio7.61 % Short Interest to Float1.4 R-squared0.31308
BETA0.920945 52-week High/Low65.37 / 39.37 Stddev0.103085

Are you looking for this stock instead?

View SEC Filings from ALC instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 7 -28.57% 3 (0.2%) 4 (0.26%) -25.0%
Funds Holding: 528 538 -1.86% 107 (6.98%) 108 (6.91%) -0.93%
13F shares: 243.012 Million 257.959 Million -5.79% 69.501 Million 63.137 Million 10.08%
% Ownership 49.7706 52.832 -5.79% 14.2343 12.931 10.08%
New Positions: 63 75 -16.0% 15 16 -6.25%
Increased Positions 160 175 -8.57% 38 41 -7.32%
Closed Positions 67 92 -27.17% 15 17 -11.76%
Reduced Positions 198 202 -1.98% 40 41 -2.44%
Total Calls 719.361 Thousand 435.264 Thousand 65.27% 79.3 Thousand 133.1 Thousand -40.42%
Total Puts 938.837 Thousand 1.115 Million -15.81% 154.5 Thousand 110.2 Thousand 40.2%
PUT/CALL Ratio 1.31 2.56 -48.83% 1.95 0.83 134.94%
1 hedge funds and active managers as identified by through public filings.

Funds Holding ALC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)


Open Market Sells (S)


Exercise Derivative Conversion (M)


Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments